Top Tweets for #ImmunityBio
$IBRX の記憶型ナチュラルキラー細胞（M-ceNK）プラットフォームが、現在爆発的な実需を生んでいる膀胱がん領域を遥かに超え、最も凶悪な難治性がんの一つである「小細胞肺がん（SCLC）」をも物理的に制圧しつつある隠れたエビデンスを露わにしています🏥🛡️ #IBRX #ImmunityBio #Anktiva #MceNK
$IBRX M-ceNK cells look highly active against SCLC models, and ImmunityBio may already have patent protection around this angle.
quietly important discovery if true.
And back up we go $ibrx the stock market and world ain’t fair y’all it’s a rigged ass game to keep the elites winning and retail broke and losing. They control everything. Remember that and don’t fall for fake ass dips like the one we just had #immunitybio #ibrx immunity bio
$ibrx if you believe in the company long term. Ignore this dip made by the trash shorts. They are tryna scare you. Just hold and buy more. Idiots are giving you a gift. As for the insider sell it was tax write off. Nothings changed
$IBRX ：浮動株の枯渇と、約40%もの空売り残高。実需に裏付けられた歴史的ショートスクイーズの引き金📈🛡️
@ManniloTrader がチャートと共に提示した強気の叫びは、 $IBRX がテクニカル・需給の両面において、極めて爆発的な臨界点に達している現実を突いています。#IBRX #ImmunityBio #Anktiva
$IBRX the FLOAT must be gone by now. May the #MOASS begin.
This #ShortSqueeze will be epic.
Increasing revenue, worldwide 🌐 expansion, new approvals coming, lots of trials with good interim data, Lymphopenia booster, sepsis trial,...
Just bought $IBRX again. $6.95 #ImmunityBio
You guys gotta see this clip. I captured the most interesting part it's about 3-4 mins long. Must watch. @hubermanlab is a leading authority in the health and wellness space. We need to get the Dr on his show.
Major signal on Lymphocytes. #IBRX @DrPatrick
Dr Bakri
“So if you have a robust amount of lymphocytes with low amount of monocytes, that suggests you have a more, let's say, ready and robust immune state. So $3 lab test that everybody gets, almost every lab testing company now checks it, and no one really reports on it. But you can kind of stratify people into disease risk based on that score.ʼʼ
Huberman asks......
ʼʼOut of 100 randomly polled physicians who receive their license in the United States, how many of them probably know what you just described?ʼʼ
Zero.
Why not?
It's like rabbit holes that you kind of go down and find out. Like I've been lobbying everyone in the hospital to look at this.”
So to summarize the medical establishment does not train on this bio marker. 🧐🤯😱Think about how early Immunity Bio is? #wild #unstoppable
https://t.co/vrmBGYlFOO
これが本格実装されると、ANKTIVAのような破壊的なプラットフォームを持つ $IBRX が、既存のがん治療市場（メガファーマのドル箱）を想定以上の超ハイスピードで侵食（社会実装）していくことになります。#IBRX #ImmunityBio #Anktiva #FDA
Why ImmunityBio’s ANKTIVA cost analysis could intensify the bladder cancer value debate https://t.co/2rNvUxOWOZ Bladder cancer drugs face a value test. ImmunityBio’s ANKTIVA analysis raises new questions on cost, response durability and access. #ImmunityBio #ANKTIVA #IBRX #BladderCancer #NMIBC #Oncology #HealthEconomics #Biotech #CancerCare #ISPOR2026 @ImmunityBio
Part 1 and Part 2 are now available :)
Please find
Part 1, here: https://t.co/TxtK0HNCSg
Part 2, here: https://t.co/bESyzeOdeW
$INKT $IBRX Happy Friday #immunitybio #cancer
New MiNK data presented at #ATS2026 and published in Clinical Immunology Communications showed pathogen suppression, lung immune-cell recruitment and tissue repair pathway activation following sequential agenT-797 + Anktiva® (N-803).
Read more: https://t.co/JEtcHAWLQX
$INKT #ARDS #iNKT
Papillary NMIBC could become the next commercial test for ImmunityBio’s ANKTIVA franchise https://t.co/fnJGih7x2H ANKTIVA already has an NMIBC foothold. The harder test is whether FDA reviewers accept extrapolation into papillary-only disease. #ImmunityBio #ANKTIVA #BladderCancer #NMIBC #CancerImmunotherapy #Biotech #FDA #PDUFA #Oncology #ClinicalTrials @ImmunityBio
Have a wonderful week everyone. We win together. We win for humanity. We win for those struggling with cancer and those who will also struggle in the future (we are all susceptible) so we push forward for the betterment of humanity $ibrx #immunitybio
Happy Monday $IBRX 'ers,
If you haven't watched yet, here is my summary of Dr. Patrick's exclusivity announcement with the Tokyo-172 BCG strain. Please leave a comment if you enjoyed it and retweet this!
https://t.co/xqy58JINMZ
#immunitybio @AmerUrological @ImmunityBio #ibrx #cancer #research #AI #supplychain @Merck
ImmunityBio Announces Exclusive Supply of Tokyo-172 BCG (ImmunoBladder) to Address 14 Year US Shortage Following Randomized Clinical Trial Comparing Tokyo to TICE Strain.
Learn more here: https://t.co/FAhapwwDmk
@DrPatrick #AUA26
日本では、再生医療安全性確保法のもと、NK細胞療法ががん再発予防やアンチエイジングの「新たな道」として市民権を得ています。この成熟した土壌こそが、 $IBRX のプラットフォームを展開する上で世界最高のテストベッドとなります。
#IBRX #ImmunityBio #Anktiva #NKcells
$IBRX ：日本という「NK細胞の聖地」で加速する、次世代免疫療法の社会実装🏥🇯🇵
日本におけるNK細胞療法への強い関心と整備された法規制は、パトリック博士の訪日目的を雄弁に物語っています。
#IBRX #ImmunityBio #Anktiva #NKcells #JapanMedicine #RegenerativeMedicine #Investing #投資
$IBRX Japan’s strong interest in NK cell therapy may explain Patrick’s visit. Big potential ahead for scalable robotics and expansion.
ブラック・スワンが「ポジティブ」に作用する稀なケース。規制のトップが変わることで、グローバルな承認獲得に向けたリーダーシップをFDAが取り戻す、という論理的なシナリオが浮上しています。#IBRX #ImmunityBio #FDA #MartyMakary #Anktiva #Biotech #Investing #投資
$IBRX ：FDA長官の辞任という「ポジティブ・ブラックスワン」。規制の停滞が終わり、承認への道が加速するか🏥🛡️
2026年5月12日のマーティ・マカリ（Marty Makary）FDA長官の電撃辞任は、 $IBRX にとって歴史的な転換点となる可能性があります。#IBRX #ImmunityBio #FDA #Anktiva #Biotech #Investing
$IBRX
THE REMOVAL OF THE FDA HEAD IS A POSITIVE BLACK SWAN EVENT FOR IMMUNITYBIO.
With all my scenarios, this one I had not even thought about. Makary was definitely an archenemy of @DrPatrick
With him gone, it seems logical that the FDA can take back the global lead in authorizations for ImmunityBio.
As always, it will take the market a few days to decide in which direction it should go. But this news is a strong positive !
$isrg $ibrx
It’s time!!!!!
2 Ways $IBRX Will Make Huge Revenue – #1 Is Anktiva…..But #2 Could Shock You #immunitybio
https://t.co/HOdIGVZos8
Marty, you took on entrenched interests, challenged the status quo, and never lost sight of the American people we serve. You pushed forward critical reforms and helped advance our mission to Make America Healthy Again. I’m grateful for your courage and your friendship. Wishing you the very best in your next chapter.
I also want to thank Kyle Diamantas for stepping in as Acting Commissioner — his leadership has already delivered remarkable wins on the MAHA food agenda, and I have full confidence in his continued work. We have an outstanding team at FDA, and the work continues without pause. The search for a new Commissioner is already underway, and we will move forward with urgency.
@stonkstradamus 2 Ways $IBRX Will Make Huge Revenue – #1 Is Anktiva…..But #2 Could Shock You #immunitybio
https://t.co/HOdIGVZos8
$IBRX：全人類 80億人がターゲット。免疫の再起動という、バイオテック史上最大の TAM🏥🛡️
@alc2022 氏が提示した「$IBRXは 5兆ドル企業になり得る」という視座は、ANKTIVA を単なるがん治療薬ではなく、人類の免疫系を最適化するOSと定義したことに本質があります。#IBRX #ImmunityBio #Anktiva
$IBRX is probably a $5T company in the making
Everyone’s going to need to reboot their immune system at least a few times in their life
The TAM is 8B people
Ozempic makes you skinny, Anktiva keeps you alive
@MK2forU 2 Ways $IBRX Will Make Huge Revenue – #1 Is Anktiva…..But #2 Could Shock You #immunitybio
https://t.co/HOdIGVZos8
Just did a video on this scale
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.8M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111.1M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.8M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91M followers
KATY PERRY
@katyperry
87.9M followers
Taylor Swift
@taylorswift13
81.7M followers
Lady Gaga
@ladygaga
73.3M followers
Virat Kohli
@imvkohli
70.3M followers
Kim Kardashian
@kimkardashian
69.9M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64M followers
Neymar Jr
@neymarjr
63.1M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61M followers
X
@x
60.8M followers